Stock Events

Stock Events

Aclaris Therapeutics (8AT.MU) Q2 2026 Earnings

12MayConfirmed

Q1 2026

Next

-0.14

-0.13

-0.13

-0.12

Details

Expected EPS

-0.1344985135

Actual EPS

N/A

Surprise EPS

0.13

Surprise Percent

+100%

Description

Aclaris Therapeutics (8AT.MU) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.